Project Grant R01MH137205
Award Date
5/1/25
Completion Date
2/28/30
Dollars Obligated
$836K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award, totaling $183,663, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant supports research conducted by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to integrate the analysis of common, rare, and structural genetic variation to better define the genetic architecture of neuropsychiatric disorders, including autism spectrum disorder,...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,354,604 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on targeting the ARC protein complex to improve cognitive deficits in psychotic disorders such as schizophrenia. The key objectives of this 5-year research project are to: 1) derive a quantitative structure-activity relationship to optimize...
The National Institute of Mental Health (NIMH) awarded a $129,288 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop statistical methods and analytical resources for fine-mapping genetic variants associated with psychiatric disorders. The key products and services to be delivered under this 2-year grant (8/1/2024 - 7/31/2026) include: 1) developing a local-ancestry-aware...
This $226,877 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is supporting the development of a microphysiological model of the neurovascular unit capable of demonstrating neurovascular coupling. The key goals are to: 1) characterize the ability of smooth muscle cells and endothelial cells to vasoconstrict and vasodilate in response to vasoactive agents, 2) produce a population of induced pluripotent stem...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will advance functional MRI (fMRI) techniques to study cerebral cortical layers in the human brain. The $156,656 award, effective March 1, 2025 through December 31, 2027, will support research to validate and apply a novel "linescan fMRI" method that can achieve higher spatial resolution than conventional laminar fMRI. The awardee, The...
The U.S. National Institute of Mental Health (NIMH) awarded a $196,120 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on "Preventing Homelessness in Transitioning Service Members with Mental Illness." The project, which runs from January 1, 2025 to December 31, 2029, aims to develop and evaluate innovative approaches to support transitioning...
This $908,174 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to improve understanding of the cellular and molecular mechanisms underlying schizophrenia. The primary objectives are to: 1) Replicate and expand on prior findings regarding associations between electrophysiological variables in patient-derived induced pluripotent stem cell (iPSC) models and clinical/cognitive phenotypes of...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $182,528 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a multifocal transcranial magnetic stimulation (TMS) system combined with electroencephalography (EEG) to study network-level brain connectivity in major depressive disorder. The project aims to optimize targeting of brain subregions...
This Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to characterize the neuro-immune and placental profile of a two-hit mouse model involving maternal Toll-like receptor 7 (TLR7) stimulation during pregnancy and early postnatal resource deprivation stress. The $245,475 award to The General Hospital Corporation, doing business as Massachusetts General Hospital, aims to determine whether...
The National Institute of Mental Health (NIMH) awarded a $831,180 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to advance precision psychiatry research and clinical application. The funding will support a 5-year collaborative project named PSYCHEMERGE, which aims to develop a federated learning platform for generalizable and bias-aware algorithms, integrate genomic and clinical data for...